CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Scientific Officer sold 68,412 shares at $7.35 ($502,828)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Scientific Officer sold 1,698 shares at $9.00 ($15,282)
- 144 Insider Sale of Securities
- 4 Option exercise Chief Financial Officer acquired 2,500 shares (option exercise)
- 4 Open-market sale Director sold 36,291 shares at $7.19 ($260,932)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 53,000 shares at $7.59 ($402,270)
- 4 Open-market sale Director sold 10,000 shares at $7.05 ($70,500)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief People Officer sold 20,875 shares at an average $6.99 ($145,845)
- 4 Open-market sale Chief Commercial Officer, MRD sold 26,023 shares at $6.98 ($181,641)
Page 11 of 42 · 836 filings